Home
Scholarly Works
Interim safety results of a global early access...
Conference

Interim safety results of a global early access protocol (EAP) of abiraterone acetate (AA) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) progressing after taxane-based chemotherapy

Authors

George DJ; McGowan T; Daugaard G; Flaig TW; Geczi L; Hotte SJ; Mainwaring PN; Saad F; Smith MR; Souza C

Volume

31

Publisher

LIPPINCOTT WILLIAMS & WILKINS

Publication Date

May 20, 2013

Name of conference

49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)

Conference place

Chicago, IL

Conference start date

May 31, 2013

Conference end date

June 4, 2013

Conference proceedings

JOURNAL OF CLINICAL ONCOLOGY

Issue

15

ISSN

0732-183X

Labels

Fields of Research (FoR)

Contact the Experts team